About This Event

Kardigan (Nasdaq: KARD), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Tassos Gianakakos, co-founder, chief executive officer, and chair, and Jay Edelberg, M.D., Ph.D., co-founder and chief medical officer, rings the Opening Bell.